MCRP 4-11.1C governs multiservice tactics, techniques, and procedures for treatment of biological warfare agent casualties.
View MCRP 4-11.1C on armypubs.army.mil
MCRP 4-11.1C covers biological warfare agents, casualty recognition, infection control, medical reporting, specimen collection, and identification technologies. It includes treatment, prevention, surveillance, warning and detection, and management of bacterial, viral, and toxin agents.
Applies to: This publication has been prepared under our direction for use by our respective commands and other commands as appropriate.
The Scowcroft Memorandum authorized vulnerability studies but not the creation of novel pathogens or weaponization techniques for purposes of threat assessment. (paragraph 1-19)
Health officials of the U.S. Armed Forces medical departments are required to centrally report all occurrences of conditions with urgent or significant public health and/or military operational implications. (paragraph 2-23)
Adequate, accurate, and timely intelligence is required in order to develop an effective defense against BW. (paragraph 2-11)
Employ standard precautions for handling, treating, and moving all active cases. (paragraph 3-17)
Specimens must be taken during convalescence, the terminal stages of infection or toxicosis or postmortem during autopsy. (paragraph 1-22)